Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Alcon stock in Canada | $81.54
Own Alcon shares in just a few minutes.
Alcon AG is a medical instruments & supplies business based in the US. Alcon shares (ALC) are listed on the NYSE and all prices are listed in US Dollars. Alcon employs 23,000 staff and has a trailing 12-month revenue of around USD$7.8 billion.
How to buy shares in Alcon
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ALC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Alcon stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Alcon?
- Has coronavirus impacted Alcon shares?
- Alcon shares summary
- Compare share dealing platforms
- Is Alcon stock a buy or sell?
- Alcon performance over time
- Can I short Alcon shares?
- Are Alcon shares over-valued?
- Alcon's financials
- How volatile are Alcon shares?
- Does Alcon pay a dividend?
- Other common questions
How has Coronavirus impacted Alcon's stock price?
Since the stock market crash in March caused by coronavirus, Alcon's stock price has had significant positive movement.
Its last market close was $81.54, which is 22.20% up on its pre-crash value of $63.44 and 107.11% up on the lowest point reached during the March crash when the stocks fell as low as $39.37.
If you had bought $1,000 worth of Alcon stocks at the start of February 2020, those stocks would have been worth $671.24 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,373.13.
Alcon stock priceUse our graph to track the performance of ALC stocks over time.
Alcon shares at a glance
|Latest market close||$81.54|
|52-week range||$55.71 - $87.49|
|50-day moving average||$82.26|
|200-day moving average||$74.42|
|Wall St. target price||$85.83|
|Dividend yield||$0.113 (0.14%)|
|Earnings per share (TTM)||$0.37|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Alcon price performance over time
|1 week (2021-10-14)||3.25%|
|1 month (2021-09-19)||N/A|
|3 months (2021-07-23)||14.51%|
|6 months (2021-04-23)||7.57%|
|1 year (2020-10-22)||33.30%|
|2 years (2019-10-22)||40.34%|
|3 years (2018-10-19)||N/A|
|5 years (2016-10-19)||N/A|
Is Alcon under- or over-valued?
Valuing Alcon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alcon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Alcon's P/E ratio
Alcon's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 210x. In other words, Alcon shares trade at around 210x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Alcon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.8 billion.
The EBITDA is a measure of a Alcon's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$7.8 billion|
|Operating margin TTM||6.68%|
|Gross profit TTM||$3.1 billion|
|Return on assets TTM||1.18%|
|Return on equity TTM||0.97%|
|Market capitalisation||$38.2 billion|
TTM: trailing 12 months
Shorting Alcon shares
There are currently 7.5 million Alcon shares held short by investors – that's known as Alcon's "short interest". This figure is 7.7% up from 6.9 million last month.
There are a few different ways that this level of interest in shorting Alcon shares can be evaluated.
Alcon's "short interest ratio" (SIR)
Alcon's "short interest ratio" (SIR) is the quantity of Alcon shares currently shorted divided by the average quantity of Alcon shares traded daily (recently around 663226.15658363). Alcon's SIR currently stands at 11.24. In other words for every 100,000 Alcon shares traded daily on the market, roughly 11240 shares are currently held short.
However Alcon's short interest can also be evaluated against the total number of Alcon shares, or, against the total number of tradable Alcon shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alcon's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Alcon shares in existence, roughly 20 shares are currently held short) or 0.0152% of the tradable shares (for every 100,000 tradable Alcon shares, roughly 15 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Alcon.
Alcon share dividends
Dividend payout ratio: 11.32% of net profits
Recently Alcon has paid out, on average, around 11.32% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.14% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Alcon shareholders could enjoy a 0.14% return on their shares, in the form of dividend payments. In Alcon's case, that would currently equate to about $0.113 per share.
While Alcon's payout ratio might seem low, this can signify that Alcon is investing more in its future growth.
Alcon's most recent dividend payout was on 6 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 4 May 2021 (the "ex-dividend date").
Alcon share price volatility
Over the last 12 months, Alcon's shares have ranged in value from as little as $55.708 up to $87.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Alcon's is 0.4773. This would suggest that Alcon's shares are less volatile than average (for this exchange).
Alcon, Inc. , an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S. A.
Frequently asked questions
Alcon in the news
Algoma Central Corporation to Issue Third Quarter 2021 Financial Results on November 3, 2021
Unusual Options Activity in Alcon (ALC), Nikola (NKLA), and NuVasive (NUVA)
Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care
More on investing
Stock trading doesn’t have to be expensive. Using Finder’s proprietary algorithm, we’ve identified the best cheap Canadian and US stocks to buy now.Read more…
Steps to owning and managing Cue Health stocks, with 24-hour and historical pricing before you buy.Read more…
Steps to owning and managing ARBK stock, with 24-hour and historical pricing before you buy.Read more…
More guides on Finder
How to buy AirSculpt Technologies (AIRS) stock in Canada when it goes public
Everything we know about the AirSculpt Technologies IPO, plus information on how to buy in.
How to buy Candela Medical (CDLA) stock in Canada when it goes public
Everything we know about the Candela Medical IPO, plus information on how to buy in.
How to buy Ensemble Health Partners (ENSB) stock in Canada when it goes public
Everything we know about the Ensemble Health Partners IPO, plus information on how to buy in.
How to buy Fluence Energy (FLNC) stock in Canada when it goes public
Everything we know about the Fluence Energy IPO, plus information on how to buy in.
How to buy GlobalFoundries (GFS) stock in Canada when it goes public
Everything we know about the GlobalFoundries IPO, plus information on how to buy in.
How to buy LianBio (LIAN) stock in Canada when it goes public
Everything we know about the LianBio IPO, plus information on how to buy in.
How to buy Rent the Runway (RENT) stock in Canada when it goes public
Everything we know about the Rent the Runway IPO, plus information on how to buy in.
How to buy Solo Brands (DTC) stock in Canada when it goes public
Everything we know about the Solo Brands IPO, plus information on how to buy in.
How to buy Udemy (UDMY) stock in Canada when it goes public
Everything we know about the Udemy IPO, plus information on how to buy in.
How to buy Arteris (AIP) stock in Canada when it goes public
Everything we know about the Arteris IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.